Clinicians frequently encounter diagnostic dilemmas when identifying the precise etiology of acute abdominal pain. In severe acute pancreatitis, routine laboratory workup focuses heavily on common etiologies such as biliary obstruction and ethanol consumption. However, metabolic drivers, including primary hyperparathyroidism, can escape early detection when initial biochemical markers appear deceptively normal. Saponification of retroperitoneal fat and systemic inflammatory reactions often depress serum calcium during early disease phases. Therefore, adopting protocolized serial calcium monitoring provides essential diagnostic vigilance, ensuring that underlying endocrine disorders receive prompt identification and appropriate targeted intervention before life-threatening complications emerge.

The Diagnostic Paradox of Calcium in Pancreatitis

Clinicians traditionally consider hypocalcemia as a reliable prognostic marker in severe acute pancreatitis. As systemic inflammation progresses, extensive retroperitoneal fat necrosis releases free fatty acids that bind circulating ionized calcium. Consequently, profound calcium saponification occurs within peripancreatic tissues, precipitating a rapid decline in circulating levels. This phenomenon regularly masks preexisting hypercalcemic disorders during the initial hospital presentation.

When patients present without typical risk factors like gallstones or alcohol abuse, physicians often search for obscure etiologies. Primary hyperparathyroidism represents an infrequent yet clinically critical cause of pancreatitis. Excess parathyroid hormone drives extracellular calcium accumulation, which triggers premature intra-acinar trypsinogen activation and organ autodigestion. However, early saponification can balance or overwhelm this metabolic excess during initial admission. As a result, the measured serum calcium may sit paradoxically within the low or normal reference range. Clinicians who rely solely on baseline electrolyte panels might mistakenly dismiss hyperparathyroidism. Therefore, understanding this biochemical contradiction remains paramount for critical care teams managing unexplained pancreatic inflammation.

Deceptive Clinical Presentation: A Case Analysis

A recent clinical case vividly demonstrates how primary hyperparathyroidism can conceal itself beneath severe abdominal pathology. A 42-year-old male developed severe necrotizing pancreatitis without any history of gallstone disease, malignant neoplasms, or alcohol consumption. Persistent organ failure extended beyond 48 hours, placing him in the critical care category of the Revised Atlanta Classification.

On admission, his corrected serum calcium level registered at the low end of normal. This baseline finding initially reinforced the assumption of purely inflammatory hypocalcemia. However, serial measurements told a strikingly different story as fluid resuscitation continued. By hospital day three, serum calcium concentrations began a sharp upward trajectory, quickly exceeding normal upper reference limits on day four. Furthermore, the patient experienced a massive calcium surge that reached a peak of 18 mg/dL on day twenty-one. Elevated intact parathyroid hormone levels subsequently confirmed primary hyperparathyroidism on hospital day twenty-four, and cervical ultrasonography revealed a distinct parathyroid mass. This stark evolution emphasizes that early normocalcemia reflects transient peripheral saponification.

Clinical Value of Serial Calcium Monitoring in Critical Care

This complex case underscores why serial calcium monitoring serves as an indispensable tool in medical intensive care units. Physicians routinely check electrolytes during initial triage, but subsequent monitoring often focuses exclusively on trending hematocrit, creatinine, or blood gases. Nevertheless, unmasking hidden hypercalcemia requires frequent, structured biochemical testing throughout the entire recovery timeline.

Because fat saponification consumes calcium during early necrotic expansion, circulating levels remain artificially depressed until active tissue destruction stabilizes. Once systemic necrotizing processes decelerate, continuous parathyroid hormone secretion drives uninhibited skeletal resorption and renal calcium reabsorption. Consequently, serum calcium values can rise abruptly during the subacute phase of illness. Moreover, severe hypercalcemia induces profound physiological instability, including nephrogenic diabetes insipidus, severe hypovolemia, cardiac arrhythmias, and encephalopathy. By maintaining vigilant serial monitoring, critical care teams can detect early hypercalcemic inflections before hypercalcemic crisis causes secondary organ damage. In patients suffering from idiopathic acute pancreatitis, trending calcium levels provides crucial clinical clues that prevent devastating diagnostic delays.

Emergency Management of Severe Hypercalcemic Crisis

Managing acute hypercalcemic crisis within the setting of multiorgan failure presents substantial therapeutic challenges. When corrected calcium reached 18 mg/dL in this case, severe renal dysfunction compounded the patient's critical illness. Consequently, the medical team deployed an aggressive multimodal pharmacological and extracorporeal strategy.

First, the team instituted continuous hemodiafiltration using low-calcium dialysate. This renal replacement modality efficiently extracted circulating calcium while mitigating fluid overload in the presence of established oliguric kidney injury. In addition, pharmacotherapy included elcatonin to provide rapid inhibition of osteoclastic bone resorption. Because calcitonin analogs exhibit tachyphylaxis, clinicians administered intravenous bisphosphonate therapy using zoledronic acid to sustain skeletal suppression. Furthermore, the team incorporated cinacalcet, an allosteric calcium-sensing receptor agonist, to suppress parathyroid hormone release from the autonomous adenoma. Combining these agents enabled significant reductions in serum calcium levels prior to operative intervention. Therefore, precise multidisciplinary coordination between intensivists, nephrologists, and endocrinologists remains essential to balance drug toxicity against hypercalcemic cardiac arrest.

Surgical Intervention and Definitive Endocrine Resolution

While medical stabilization resolves immediate life threats, definitive cure for primary hyperparathyroidism requires targeted surgical resection. In this patient, clinicians scheduled a focused parathyroidectomy on hospital day thirty-five once medical therapy stabilized metabolic parameters.

Histopathological evaluation confirmed a benign solitary parathyroid adenoma, which represents the underlying etiology in approximately eighty percent of primary hyperparathyroidism cases. Remarkably, serum calcium normalized by day thirty-six, illustrating the immediate biochemical cure achieved through surgical extirpation. The rapid clearance of excess parathyroid hormone halts bone resorption immediately, allowing normal calcium homeostasis to reestablish. Nevertheless, the patient's extensive pancreatitis course demanded prolonged supportive care. The patient subsequently developed complex peripancreatic complications, including large intra-abdominal abscesses that required percutaneous drainage. After prolonged intensive rehabilitation, clinicians successfully transferred the patient to a specialized recovery facility on day 170. This protracted trajectory demonstrates that curing the endocrine trigger does not eliminate preexisting pancreatic necrosis. Thus, clinicians must maintain comprehensive surgical and nutritional support throughout recovery.

How does severe acute pancreatitis mask underlying primary hyperparathyroidism on admission?

Severe acute pancreatitis triggers extensive peripancreatic and retroperitoneal fat necrosis. As pancreatic lipases hydrolyze triglycerides into free fatty acids, circulating calcium ions bind to these acids through saponification. This local consumption rapidly pulls calcium from circulation into peripancreatic tissues. Consequently, baseline serum calcium levels appear normal or low despite preexisting primary hyperparathyroidism. Clinicians might overlook the underlying endocrine disorder unless they continue monitoring calcium levels as tissue necrosis subsides.

When should clinicians recheck serum calcium in unexplained acute pancreatitis?

Clinicians should systematically recheck corrected calcium daily during the acute phase, especially between hospital days three and seven. When patients lack common risk factors such as gallstones or alcohol abuse, unexplained pancreatitis warrants heightened suspicion. As fluid resuscitation restores intravascular volume and saponification plateaus, true underlying hypercalcemia reveals itself. If serum calcium levels trend upward or exceed normal limits, physicians must immediately measure intact parathyroid hormone to confirm hyperparathyroidism.

What are the first-line emergency therapies for hypercalcemic crisis with renal failure?

Emergency management requires immediate multimodal intervention to lower dangerous serum calcium concentrations while protecting vulnerable organs. Continuous hemodiafiltration with calcium-free or low-calcium dialysate provides rapid clearance when concurrent renal impairment limits forced diuresis. Concurrently, physicians administer elcatonin or calcitonin for rapid skeletal suppression alongside the calcimimetic agent cinacalcet. Furthermore, judicious intravenous bisphosphonate therapy helps maintain calcium suppression. Once metabolic stabilization occurs, targeted surgical parathyroidectomy provides definitive cure for the underlying functional adenoma.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Yokota M et al. Serial Calcium Monitoring Revealed Primary Hyperparathyroidism in Severe Acute Pancreatitis: A Case Report. Acute Med Surg. 2026 undefined undefined. doi: 10.1002/ams2.70167. PMID: 42859844.
2. Bilezikian JP, Silverberg SJ, Bandeira F, et al. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res. 2022;37(11):2293-2314.
3. Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400-1415.